The Homeopathy Files
Share This Post
Related Articles
-
May 20, 2021 75FDA Threatens to Ban Critical Toxin Protection Supplement
On shaky legal grounds, the FDA has targeted N-acetylcysteine (NAC), an important antioxidant supplement. Action Alert! The FDA has declared that NAC, a vital antioxidant with a number of important health benefits, is not a legal dietary supplement. This is a direct threat to a supplement that m...
-
Jan 13, 2009 2FDA Petition Calls for Changes in Diabetes Drug Labeling
On December 18, a petition was filed with the FDA by the Physicians Committee for Responsible Medicine. It asks the FDA to require that diabetic medications in the thiazolidinedione class of drugs like Avandia include labeling that states a low-fat vegan diet has been shown to be as effective or mor...
-
Aug 18, 2009 0
Alliance for Natural Health Takes Aim at the Marketing of Splenda on Facebook
Alliance for Natural Health (ANH), the British counterpart to AAHF, has published a brilliant position paper on the marketing campaign being used to sell Splenda Mist. (more…)...
-
Sep 20, 2016 3Will Monsanto Now Try To Hide?
A $66 billion buyout by the German pharmaceutical giant Bayer could make it harder for consumers to avoid products from the biotech behemoth. Action Alert! The number of companies controlling our food supply is about to shrink even further now that Bayer has bought Monsanto for $66 billion in cash,...
-
Jun 2, 2016 0Meat Glue Sales Pitch
Action Alert Read Full Story...
-
Nov 13, 2019 0Valsartan and cancer, liver damage
Valsartan is an angiotensin-receptor blocker which is prescribed to patients with high blood pressure or congestive heart failure. Valsartan is widely manufactured overseas. Unfortunately, the Food and Drug Administration (FDA) has found Valsartan drugs made by generic manufacturers to be contaminat...
-
Nov 24, 2015 96GMOs Are 125 Times More Deadly Than Previously Thought
...
-
May 19, 2009 0
AAHF Asks Senate Finance Committee to Prioritize Privacy, Transparency, and Independent Research
Last week, AAHF contacted the Senate Finance Committee, which is working on proposals to improve patient care and reduce healthcare costs. We asked committee members to look at two sections in particular: Health Information Technology (HealthIT), and Comparative Effectiveness Research (CER). (more&h...
-
Jan 10, 2017 12016 Year In Review
...
-
Jun 27, 2018 1What They Won’t Tell You About Sunscreen
Take Action!...
Leave a Reply